How long does the prior authorization process take for Pemazyre?

Blue Cross Blue Shield typically processes prior authorization requests within 14 business days for non-urgent requests and 72 hours for urgent requests. New York insurance law provides additional patient protections for cancer medications.

What should I do if my Pemazyre coverage is denied by BCBS?

If denied, you can file an internal appeal with Blue Cross Blue Shield within 180 days. If the internal appeal is denied, you can request an external review through New York's independent review process within 60 days.

What documentation is needed for Pemazyre prior authorization?

Required documentation includes FGFR testing results confirming appropriate mutations, complete medical history, records of prior treatments and their outcomes, and a detailed letter of medical necessity from your oncologist.

By Counterforce Health Team in Pemazyre (pemigatinib) — 13 Nov 2025

How to Get Pemazyre (Pemigatinib) Covered by Blue Cross Blue Shield in New York: Complete Guide with Appeals Process

Quick Answer: Getting Pemazyre Covered in New York

Eligibility: Pemazyre (pemigatinib) requires prior authorization from Blue Cross Blue Shield for FGFR2+ cholangiocarcinoma or FGFR1+ myeloid/lymphoid neoplasms after prior therapy failure. Fastest path: Submit PA request with FGFR testing results, prior treatment records, and oncologist letter of medical necessity. Start today: Call your BCBS member services to confirm formulary status and request PA forms. New York law provides 72-hour expedited appeals for urgent cases and external review rights through the Department of Financial Services.

New York Insurance Laws for Specialty Cancer Drugs
BCBS Prior Authorization Requirements
Fastest Path to Approval
Common Denial Reasons & Solutions
New York Appeals Process
Step Therapy Protections
Continuity of Care Rights
Cost Assistance Programs
When to Contact State Regulators
FAQ

Why New York State Rules Matter for Pemazyre Coverage

New York has some of the nation's strongest patient protection laws for specialty oncology medications like Pemazyre. These state regulations work alongside your BCBS plan policies to provide additional rights and faster resolution pathways.

Key New York Protections:

72-hour expedited appeals for urgent drug denials that could jeopardize health
Independent clinical review by oncology specialists for medical necessity denials (effective 2025)
Step therapy limits: Starting January 2026, no more than two drugs can be required before accessing preferred therapy
External review rights through the Department of Financial Services with binding decisions

Important Note: These protections apply to state-regulated (fully insured) BCBS plans. Self-funded employer plans (ERISA) may have different rules, though some voluntarily adopt similar protections.

BCBS Prior Authorization Requirements for Pemazyre

Blue Cross Blue Shield plans in New York typically require prior authorization for Pemazyre due to its specialty status and high cost. Here's what you need to know:

Coverage Requirements Table

Requirement	What It Means	Documentation Needed
FDA-approved indication	Unresectable/metastatic cholangiocarcinoma with FGFR2 fusion OR R/R myeloid/lymphoid neoplasms with FGFR1 rearrangement	Pathology report, FGFR testing results
Prior therapy failure	At least one previous systemic treatment	Treatment records, progression notes
Oncologist prescription	Prescribed by or in consultation with cancer specialist	Provider credentials verification
Appropriate dosing	Per FDA labeling (13.5mg daily, 21-day cycles)	Prescription details
Monitoring plan	Ophthalmologic exams, lab monitoring	Provider attestation

Source: Based on typical BCBS oncology drug policies and FDA labeling requirements

Step-by-Step: Fastest Path to Approval

Timeline: 5-15 business days for standard review, 72 hours for expedited

1. Verify Coverage Status

Who: Patient or clinic staff
Action: Call BCBS member services (number on insurance card)
Ask for: Formulary status, tier level, PA requirements
Timeline: Same day

2. Gather Required Documentation

Who: Healthcare team
Documents needed:

FGFR2 fusion/FGFR1 rearrangement test results (FDA-approved test)
Prior treatment history with dates and outcomes
Current staging/imaging showing progression
Oncologist letter of medical necessity

3. Submit Prior Authorization Request

Who: Prescribing physician's office
Method: BCBS provider portal or fax
Include: All documentation from step 2
Timeline: Submit within 24-48 hours of gathering documents

4. Request Expedited Review (If Applicable)

When: Patient's condition could deteriorate without immediate treatment
How: Call BCBS and specifically request "expedited prior authorization"
Timeline: 72-hour decision required by New York law

5. Follow Up Proactively

Action: Call BCBS every 3-5 business days for status updates
Document: Keep records of all calls, reference numbers, and representative names

Clinician Tip: Include specific language about "medical necessity based on FDA-approved indication" and reference NCCN guidelines for cholangiocarcinoma or relevant blood cancer treatment guidelines in your letter.

Common Denial Reasons & How to Fix Them

Denial Reason	Solution Strategy	Required Documentation
"No documented FGFR alteration"	Submit FDA-approved test results	FoundationOne, Guardant360, or other validated NGS report
"Off-label use"	Clarify FDA indication	Highlight exact FDA labeling language in appeal
"No prior therapy documentation"	Provide complete treatment history	Chemotherapy records, progression imaging, provider notes
"Lack of monitoring plan"	Submit ophthalmologic plan	Eye exam schedule, lab monitoring protocol
"Not medically necessary"	Request independent clinical review	Peer-reviewed literature, NCCN guidelines, specialist letter

Sources: Common BCBS denial patterns and New York appeal success strategies

New York Appeals Process for Pemazyre Denials

New York provides a robust three-level appeals system with specific timelines and protections:

Level 1: Internal Appeal with BCBS

Deadline: 180 days from denial date
Timeline: 30 days for standard, 72 hours for expedited
How to file: Written request to BCBS appeals department
Required: Copy of denial letter, medical records, provider support

Level 2: Independent Clinical Review (New 2025)

Trigger: Medical necessity denials automatically get oncology specialist review
Timeline: Same as Level 1
Benefit: Board-certified oncologist reviews your case independently

Level 3: External Appeal (Department of Financial Services)

Deadline: 4 months after final internal denial
Timeline: 30 days standard, 72 hours expedited
Cost: $25 maximum (waived for financial hardship)
Decision: Binding on BCBS
How to file: DFS External Appeal Portal or fax (800) 332-2729

Success Tip: New York's external appeal database shows that oncology drug denials are frequently overturned when proper clinical documentation is provided. Community Health Advocates can help you prepare your appeal at no cost.

Sample Appeal Language

"I am appealing the denial of Pemazyre (pemigatinib) issued on [date]. My oncologist has determined this medication is medically necessary for my FGFR2-positive cholangiocarcinoma, as documented by [test name] and confirmed by progression after [prior therapy]. This treatment is FDA-approved for my specific condition and mutation status. Under New York Insurance Law, I request expedited review due to the urgent nature of my cancer treatment."

Step Therapy Protections in New York

New York's step therapy reform provides important protections for Pemazyre patients:

Current Protections (2025):

Medical exceptions for contraindications, prior failures, or expected lack of efficacy
Override approval must be honored for 12 months or treatment duration
Plans must explain denial rationale and appeal rights

Enhanced Protections (Starting January 2026):

Maximum of two drugs required before accessing preferred therapy
Stronger documentation requirements for step therapy denials

Medical Exception Criteria

Your doctor can request a step therapy override if:

You've previously failed the required medications
The required drugs are contraindicated for your condition
The required drugs would cause adverse reactions based on your medical history
The delay would violate evidence-based treatment guidelines

Source: New York Senate Bill S4689 and current Insurance Law provisions

Continuity of Care Rights

If your oncologist leaves the BCBS network or there's a contract dispute during your Pemazyre treatment, New York law provides:

90-Day Transition Period: Continue treatment at same cost-sharing level Completion of Care: Coverage through end of treatment course if terminally ill Special Enrollment: Switch plans without penalty to maintain continuity

Important: These protections apply to state-regulated plans only. ERISA (self-funded) plans may not be required to provide these benefits.

Cost Assistance and Support Programs

Even with BCBS coverage, Pemazyre can have significant out-of-pocket costs. Here are assistance options:

Manufacturer Support

Incyte Patient Support Program: Copay assistance and free drug programs
Eligibility: Commercial insurance patients, income restrictions may apply
Contact: Incyte Patient Support (verify current link)

Independent Assistance

Good Days Foundation: Chronic disease copay assistance
Patient Access Network: Cancer medication support
CancerCare: Financial assistance and counseling

New York State Programs

Medicaid: Comprehensive coverage for eligible patients
Essential Plan: Lower-cost option for moderate-income New Yorkers
EPIC: Prescription assistance for seniors

When to Contact New York State Regulators

Contact the Department of Financial Services if:

BCBS violates appeal deadlines
You're denied expedited review for urgent cases
The plan refuses to honor step therapy overrides
You need help with external appeals

Contact Information:

Phone: (800) 342-3736 or (212) 480-6400
Online: DFS Consumer Portal
Hours: Monday-Friday, 8:30 AM - 4:30 PM

Community Health Advocates (New York's Consumer Assistance Program) provides free help with insurance appeals and has a 63% success rate for first-level appeals. Call (888) 614-5400 for assistance.

At Counterforce Health, we help patients and clinicians navigate complex prior authorization and appeals processes for specialty medications like Pemazyre. Our platform analyzes denial letters and generates evidence-backed appeals tailored to specific payer requirements, helping turn denials into approvals more efficiently.

Frequently Asked Questions

Q: How long does BCBS prior authorization take for Pemazyre in New York?
A: Standard review: 5-15 business days. Expedited review (for urgent cases): 72 hours as required by New York law.

Q: What if Pemazyre isn't on my BCBS formulary?
A: Request a formulary exception with clinical justification. New York law requires plans to have a process for non-formulary drug coverage when medically necessary.

Q: Can I get expedited appeals if my cancer is progressing?
A: Yes. New York allows expedited appeals when delay could seriously jeopardize your health. Specifically request expedited review and provide documentation of urgent medical need.

Q: Does step therapy apply if I failed similar drugs outside New York?
A: Prior treatment failures should count regardless of location. Provide complete medical records showing previous treatments and outcomes.

Q: What happens if BCBS still denies after internal appeals?
A: You can file an external appeal with the New York Department of Financial Services. Their decision is binding on BCBS, and the state has a good track record of overturning inappropriate denials.

Q: Are there income limits for manufacturer copay assistance?
A: Most programs have income restrictions (typically 400-500% of federal poverty level). Contact Incyte Patient Support directly for current eligibility criteria.

Q: How do I know if my plan is state-regulated or ERISA?
A: State-regulated plans are typically individual/family plans or small group employer plans. Large employer plans are often ERISA. Check with your HR department or the plan documents.

Q: Can Community Health Advocates help with BCBS appeals?
A: Yes, CHA assists with all insurance appeals in New York at no cost, regardless of your insurer or income level.

Sources & Further Reading

From Our Advocates: "We've seen Pemazyre appeals succeed when families provide comprehensive FGFR testing documentation and clearly demonstrate prior therapy failures. The key is often getting the oncologist to write a detailed letter explaining why this specific targeted therapy is the most appropriate next step based on the tumor's molecular profile. New York's external appeal process has been particularly helpful for overturning initial denials when the clinical case is strong."

This guide provides educational information about insurance coverage and appeals processes. It is not medical advice. Always consult with your healthcare provider about treatment decisions and work with qualified professionals for insurance matters. For personalized assistance with Pemazyre coverage challenges, Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals that align with payer requirements.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.